Cargando…

Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice

BACKGROUND: Chronic increases in the levels of the inflammatory cytokine interleukin-6 (IL-6) in serum and skeletal muscle are thought to contribute to the progression of muscular dystrophy. Dystrophin/utrophin double-knockout (dKO) mice develop a more severe and progressive muscular dystrophy than...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wada, Eiji, Tanihata, Jun, Iwamura, Akira, Takeda, Shin’ichi, Hayashi, Yukiko K., Matsuda, Ryoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660454/ https://www.ncbi.nlm.nih.gov/pubmed/29078808 http://dx.doi.org/10.1186/s13395-017-0140-z

Ejemplares similares

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies
por: Janghra, Narinder, et al.
Publicado: (2016)

Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy
por: Pant, Meghna, et al.
Publicado: (2015)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin‐deficient mice and Duchenne muscular dystrophy
por: Perkins, Kelly J., et al.
Publicado: (2018)

Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model
por: Hiramuki, Yosuke, et al.
Publicado: (2023)

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches
por: Shimizu-Motohashi, Yuko, et al.
Publicado: (2019)

Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy
por: Delfín, Dawn A, et al.
Publicado: (2011)

Functional Substitution by TAT-Utrophin in Dystrophin-Deficient Mice
por: Sonnemann, Kevin J., et al.
Publicado: (2009)

Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis
por: Chen, Hung-Chih, et al.
Publicado: (2017)

Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
por: Soblechero‐Martín, Patricia, et al.
Publicado: (2021)

Brain dystrophin-glycoprotein complex: Persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy
por: Culligan, Kevin, et al.
Publicado: (2001)

Characteristics of Japanese Duchenne and Becker muscular dystrophy patients in a novel Japanese national registry of muscular dystrophy (Remudy)
por: Nakamura, Harumasa, et al.
Publicado: (2013)

Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity
por: Hardee, Justin P., et al.
Publicado: (2020)

Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy
por: Farrokhi, Vahid, et al.
Publicado: (2021)

Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening
por: Moorwood, Catherine, et al.
Publicado: (2011)

Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells
por: Sengupta, Kasturi, et al.
Publicado: (2020)

Altered sodium channel function in dystrophin/utrophin-deficient cardiomyocytes
por: Koenig, Xaver, et al.
Publicado: (2010)

The Crystal Structures of Dystrophin and Utrophin Spectrin Repeats: Implications for Domain Boundaries
por: Muthu, Muralidharan, et al.
Publicado: (2012)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy
por: Naidoo, Michael, et al.
Publicado: (2019)

Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
por: Happi Mbakam, Cedric, et al.
Publicado: (2022)

Marginal Level Dystrophin Expression Improves Clinical Outcome in a Strain of Dystrophin/Utrophin Double Knockout Mice
por: Li, Dejia, et al.
Publicado: (2010)

Myogenic Akt signaling upregulates the utrophin–glycoprotein complex and promotes sarcolemma stability in muscular dystrophy
por: Peter, Angela K., et al.
Publicado: (2009)

Disease course in mdx:utrophin(+/−) mice: comparison of three mouse models of Duchenne muscular dystrophy
por: McDonald, Abby A, et al.
Publicado: (2015)

Inactivation of Sirt6 ameliorates muscular dystrophy in mdx mice by releasing suppression of utrophin expression
por: Georgieva, Angelina M., et al.
Publicado: (2022)

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
por: Miyatake, Shouta, et al.
Publicado: (2016)

Phosphorylation alters the mechanical stiffness of a model fragment of the dystrophin homologue utrophin
por: Ramirez, Maria Paz, et al.
Publicado: (2022)

Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
por: Kemaladewi, Dwi U, et al.
Publicado: (2011)

The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene
por: Hoffman, Eric P.
Publicado: (2020)

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
por: Frank, Diane E., et al.
Publicado: (2020)

Characterization of a novel microRNA, miR-188, elevated in serum of muscular dystrophy dog model
por: Shibasaki, Hiroyuki, et al.
Publicado: (2019)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Dystrophins, Utrophins, and Associated Scaffolding Complexes: Role in Mammalian Brain and Implications for Therapeutic Strategies
por: Perronnet, Caroline, et al.
Publicado: (2010)

Prednisolone improves walking in Japanese Duchenne muscular dystrophy patients
por: Takeuchi, Fumi, et al.
Publicado: (2013)

Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location
por: Milic Rasic, V, et al.
Publicado: (2015)

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
por: Duan, Dongsheng
Publicado: (2018)

Dystrophin (DMD) Missense Variant in Cats with Becker-Type Muscular Dystrophy
por: Hilton, Stephanie, et al.
Publicado: (2023)

Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMD(J))
por: Fukushima, Kazuhiro, et al.
Publicado: (2007)

Differential Requirement for Utrophin in the Induced Pluripotent Stem Cell Correction of Muscle versus Fat in Muscular Dystrophy Mice
por: Beck, Amanda J., et al.
Publicado: (2011)

Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy
por: Levi, Oshrat, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_prsdone2gnmqhhbmf4ptgbb2rs